Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice

Published:2020-05-28 Issue:12 Volume:133 Page:1436-1444
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Feng Pan-Pan,Fang Xue-Sheng,Zhao Si-Hui,Fu Jun-Yan,Zhang Hui-Ting,Yi Yan-Lin,Li Chang-Yi,Jiang Chun-Ling,Chen Da-Peng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference29 articles.

1. Factors influencing the relapse of patients with inflammatory bowel disease;Miner;Am J Gastroenterol,1997

2. Critical assessment of thioguanine treatment for inflammatory bowel diseases: is it time to rehabilitate this treatment?;Movva;J Dig Dis,2017

3. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies;Mao;Inflamm Bowel Dis,2012

4. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells;Srikrishna;J Immunol,2001

5. Human intestinal barrier function in health and disease;König;Clin Transl Gastroenterol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Action and therapeutic targets of myosin light chain kinase, an important cardiovascular signaling mechanism;Pharmacological Research;2024-08

2. The Antioxidant Properties of Salvia verbenaca Extract Contribute to Its Intestinal Antiinflammatory Effects in Experimental Colitis in Rats;Antioxidants;2023-12-02

3. Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes;Pharmaceutics;2023-08-29

4. Corrigendum: Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice;Chinese Medical Journal;2023-01-05

5. Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application;Frontiers in Pharmacology;2022-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3